The Role of the Immune System in Fighting Cancer: From Immunity to Immunotherapy

Does a Cancer Diagnosis Mean the Beginning of the End?" Nature of the Study: It is a conceptual and documentary review designed to connect basic tumor immunology with modern clinical immunotherapies. Main Objective: To build a coherent conceptual bridge between basic tumor immunology and clinic-based immunotherapies, and to reconsider the common assumption that a cancer diagnosis is inevitably a terminal trajectory. Scope of the Study: It focuses on general mechanisms and principles across tumor types (using melanoma, lung cancer, and hematologic malignancies as illustrative examples) rather than providing an exhaustive clinical analysis or economic health-policy evaluation. Theoretical Framework: It is organized into three core chapters covering immune surveillance, mechanisms of tumor immune evasion, and immunotherapy from concept to clinical application. Study Model: It employs a four-stage conceptual trajectory model spanning immunosurveillance, immune equilibrium, immune evasion/escape, and therapeutic re-engagement.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-06
DOI
https://doi.org/10.5281/zenodo.22418079
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of the Immune System in Fighting Cancer: From Immunity to Immunotherapy

AHMED SABAH OBAID AL QAISY
Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
article

The Role of the Immune System in Fighting Cancer: From Immunity to Immunotherapy

AHMED SABAH OBAID AL QAISY
article en

Abstract

Does a Cancer Diagnosis Mean the Beginning of the End?" Nature of the Study: It is a conceptual and documentary review designed to connect basic tumor immunology with modern clinical immunotherapies. Main Objective: To build a coherent conceptual bridge between basic tumor immunology and clinic-based immunotherapies, and to reconsider the common assumption that a cancer diagnosis is inevitably a terminal trajectory. Scope of the Study: It focuses on general mechanisms and principles across tumor types (using melanoma, lung cancer, and hematologic malignancies as illustrative examples) rather than providing an exhaustive clinical analysis or economic health-policy evaluation. Theoretical Framework: It is organized into three core chapters covering immune surveillance, mechanisms of tumor immune evasion, and immunotherapy from concept to clinical application. Study Model: It employs a four-stage conceptual trajectory model spanning immunosurveillance, immune equilibrium, immune evasion/escape, and therapeutic re-engagement.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.